Japan's Daiichi Sankyo, a fast-growing player in the HER2 breast cancer space with its antibody-drug conjugate (ADC) Enhertu, is yet again receiving attention after succeeding in developing a Covid-19 mRNA vaccine.According to Daiichi Sankyo, the Japanese drug ministry approved Daichirona, its Covid
Boryung, formerly Boryung Pharmaceutical, said Monday that its new anticancer drug, BR101801, has been designated as a developmental orphan drug by the Korean Ministry of Food and Drug Safety.The designation was made to address the unmet medical needs of peripheral T-cell lymphoma (PTCL), a rare can
Ahn-gook Pharmaceutical has received a corrective order and a fine of 500 million won ($384,600) from the Korea Fair Trade Commission (FTC) for its kickback scheme.The commission said Monday that it imposed a corrective order and a fine of 500 million won on Ahn-gook Pharm for providing cash and goo
CG Invites said Friday that its stocks have been relisted on the Kosdaq market with the changed name from Crystal Genomics to CG Invites.At an extraordinary shareholder meeting in June, Crystal Genomics changed its name to CG Invites due to a change in its largest shareholder to New Lake Invites Inv
BMS Korea said Friday that its oral treatment for plaque psoriasis, Sotyktu (deucravacitinib), has obtained approval from the Ministry of Food and Drug Safety.Sotyktu is a first-in-class selective TYK2 inhibitor that moderates the activity of the IL-23/IL-17 pathway, known to play a central role in
The Institut Pasteur Korea said Thursday that it opened Korea’s first global infectious disease specimen resource bank, which will specialize in collecting and distributing infectious disease specimens.The Specimen Resource Bank was licensed on July 24 as a human derivatives bank that legally secure
Dongwha Pharm said Friday it has signed an agreement to acquire a 51 percent stake in Trung Son Pharma, a Vietnamese pharmacy chain operator, to enter the Southeast Asian pharmaceutical and beauty market in earnest.Established in 1997, Trung Son is a pharmacy chain operator operating more than 140 p
Vivozon Pharmaceutical said it has applied for a preliminary review of the Ministry of Food and Drug Safety (MFDS) to approve Unafra (opiranserine), a non-narcotic painkiller.Unafra is an investigational non-narcotic injection-type pain reliever that mitigates moderate or severe pain. It is intended
Cha Vaccine Institute and Pharos iBio have partnered to discover next-generation immunotherapies using artificial intelligence technology.Cha Vaccine Institute is developing immunotherapies utilizing its proprietary immune enhancer platform, L-pampo.In clinical studies, L-pampo has shown strong anti
Roche has made a last-minute change in the reimbursement strategy for its optic neuromyelitis drug Enspryng (satralizumab), drawing attention to whether the company can successfully put it on the list of drugs covered by insurance.The agenda item for reimbursing Enspryng will be tabled at the eighth
Asian aesthetic and cosmetic professionals recently gathered to share the latest trends and procedural know-how, pointing out that knowing the “patient’s needs” is crucial for aesthetic procedures to produce the best results.Last Sunday, they agreed at “2023 HELF in Seoul” at Grand InterContinental
The announcement on Celltrion Healthcare's contract with a U.S. Pharmacy Benefit Manager (PBM) for its Humira biosimilar Yuflyma (adalimumab) is being delayed.On Tuesday, Celltrion Healthcare disclosed the progress concerning its contract with a U.S. PBM on its website. A PBM is an independent priva
The market for Bruton tyrosine kinase (BTK) inhibitors treating B-cell malignancies has been gradually expanding globally, especially with the recent introduction of third-generation drugs.However, even the second-generation drugs are struggling, faced with the high threshold of insurance coverage i
Samsung Bioepis and Organon announced on Wednesday the interchangeable result of its Humira (adilumab) biosimilar, SB5, based on a recently conducted phase 4 study.Clinical interchangeability studies aim to assess whether one product will affect the immune response of the other once the switch betwe
LG Chem has started developing Korea's first hexavalent combined vaccine for infants, which currently depends entirely on imports.The only hexavalent combined vaccine currently available in Korea is Sanofi's Hexaxim.The company said it enrolled the first patient in Korea's phase 1 clinical trial of
Takeda Pharmaceutical Korea said Tuesday that the health insurance coverage criteria for its hemophilia A treatments, Advate and Adynovate injections, has been expanded from Aug. 1. The expanded reimbursement allows Korean patients with hemophilia A with less than 1 percent coagulation factor activi
Hanmi Pharmaceutical is sharpening its next-generation pipeline by changing and expanding the target indications of candidate treatments returned by global companies.Hanmi Pharm said Monday that it had begun preparations to launch efpeglenatide, which it has been developing as a treatment for metabo
BMS Korea said Tuesday that Onureg (azacitidine), a maintenance therapy for acute myeloid leukemia (AML), will be covered by health insurance from this month.Coverage is available for adult patients with AML who have achieved complete remission (CR) or complete remission with incomplete hematologic
Experts agreed at a recent seminar that ultrasound is essential as a guide to improve the safety and accuracy of aesthetic procedures.“Ultrasound is widely used to image many different body parts but is not well used to image facial and neck structures,” said Professor Kim Hee-jin of Yonsei Universi
GC Biopharma said Monday that its immunoglobulin blood product Alyglo (GC5107B, 10-percent intravenous immunoglobulin) has passed the U.S. Food and Drug Administration's preliminary review for marketing authorization.The company added that the U.S. FDA has also initiated the review of GC5107B for fi